Biote corp
BTMD 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
BTMD 近期報酬表現
0.18%
Biote corp
0.60%
同產業平均
0.87%
S&P500
與 BTMD 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
CLPT | Clearpoint neuro inc | 4 分 | 1 分 | 2 分 | 2 分 | 1 分 | |
SENS | Senseonics holdings inc | 3 分 | 1 分 | 1 分 | 1 分 | 1 分 | |
SHC | Sotera health co | 3 分 | 1 分 | 2 分 | 3 分 | 1 分 | |
AFIB | Acutus medical inc | 3 分 | 2 分 | 4 分 | 1 分 | 1 分 | |
TCMD | Tactile systems technology inc | 3 分 | 3 分 | 2 分 | 1 分 | 1 分 |
- CLPT Clearpoint neuro inc價值 4 分趨勢 1 分波段 2 分籌碼 2 分股利 1 分查看更多
BTMD 公司資訊
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method's proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.